Substituted diketopiperazines as oxytocin antagonists

A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a mammal in need thereof of an effective amount of a compound of the formula (I) and/or a physiologically acceptable derivative thereof, wherein the substituents have th...

Full description

Saved in:
Bibliographic Details
Main Authors HICKEY DEIRDRE MARY BERNADETTE, MILLER NEIL DEREK, BORTHWICK ALAN DAVID, MASON ANDREW MCMURTRIE, LIDDLE JOHN, WYATT PAUL GRAHAM, LIVERMORE DAVID GEORGE HUBERT, NEROZZI FABRIZIO, SOLLIS STEVEN LESLIE, HATLEY RICHARD JONATHAN, SZARDENINGS ANNA KATRIN
Format Patent
LanguageEnglish
Published 07.04.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A method of treating or preventing diseases or conditions mediated through the action of oxytocin which comprises administering to a mammal in need thereof of an effective amount of a compound of the formula (I) and/or a physiologically acceptable derivative thereof, wherein the substituents have the meaning given in the description. Disclosed are also novel compounds of formula (I) and processes for their preparation.
Bibliography:Application Number: US20050499177